TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Lab Pharma AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,613
|
2,064
|
2,196 |
| Financial expenses |
124
|
47
|
104 |
| Earnings before taxes |
188
|
-80
|
-115 |
| Total assets |
798
|
453
|
473 |
| Current assets |
615
|
215
|
239 |
| Current liabilities |
650
|
451
|
404 |
| Equity capital |
149
|
2
|
68 |
| - share capital |
44
|
47
|
50 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
18.7%
|
0.4%
|
14.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
-3.9%
|
-5.2% |
| Return on assets (ROA) |
39.1%
|
-7.3%
|
-2.3% |
| Current ratio |
94.6%
|
47.7%
|
59.2% |
| Return on equity (ROE) |
126.2%
|
-4000%
|
-169.1% |
| Change turnover |
679
|
-16
|
-1,068 |
| Change turnover % |
35%
|
-1%
|
-33% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.